166 related articles for article (PubMed ID: 26040504)
1. Prognostic impact of residual normal metaphases in acute myeloid leukemia with t(8;21)(q22;q22).
Wen L; Xia J; Wang Q; Yao H; Xie J; Pan J; Xue Y; Wu D; Chen S
Int J Hematol; 2015 Aug; 102(2):205-10. PubMed ID: 26040504
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
[TBL] [Abstract][Full Text] [Related]
3. Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.
Schoch C; Haase D; Haferlach T; Gudat H; Büchner T; Freund M; Link H; Lengfelder E; Wandt H; Sauerland MC; Löffler H; Fonatsch C
Leukemia; 1996 Aug; 10(8):1288-95. PubMed ID: 8709633
[TBL] [Abstract][Full Text] [Related]
4. Impact of residual normal metaphases in core binding factor acute myeloid leukemia.
Medeiros BC; Othus M; Fang M; Appelbaum FR; Estey EH
Cancer; 2012 May; 118(9):2420-3. PubMed ID: 21928314
[TBL] [Abstract][Full Text] [Related]
5. Prognosis and treatment outcome in patients with acute myeloid leukemia with t(8;21)(q22;q22).
Chen CC; Gau JP; Yu YB; Lu CH; Lee KD; You JY
Adv Ther; 2007; 24(4):907-20. PubMed ID: 17901040
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukaemia with t(8;21)(q22;q22.3) and loss of the X chromosome.
Mohamed M; Dun K
BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26250367
[TBL] [Abstract][Full Text] [Related]
7. Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia.
Wakita S; Yamaguchi H; Miyake K; Mitamura Y; Kosaka F; Dan K; Inokuchi K
Leukemia; 2011 Sep; 25(9):1423-32. PubMed ID: 21606963
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of acute myeloid leukemia with t(8;21) (q22;q22) and loss of Y chromosome].
Zhu CY; Yang H; Niu JH; Zhang Q; Xie XL; Wang LJ; Zhu HY; Yao ZL; Yu L; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):950-6. PubMed ID: 25130809
[TBL] [Abstract][Full Text] [Related]
9. [MICM characteristics and typing diagnosis in acute myelogenous leukemia patients (AML-M2) with complex karyotype t (2;21;8)(p12;q22;q22)].
Ma Y; Tong HX; Deng X; Zhao Y; Liu ZG; Zhang JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):12-6. PubMed ID: 19236738
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia.
Eisfeld AK; Kohlschmidt J; Schwind S; Nicolet D; Blachly JS; Orwick S; Shah C; Bainazar M; Kroll KW; Walker CJ; Carroll AJ; Powell BL; Stone RM; Kolitz JE; Baer MR; de la Chapelle A; Mrózek K; Byrd JC; Bloomfield CD
Leukemia; 2017 Jun; 31(6):1278-1285. PubMed ID: 27843138
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic effect of cytoplasmic CD79a expression in acute myeloid leukemia with t(8;21)].
Chung HJ; Chi HS; Cho YU; Lee EH; Jang S; Park CJ; Seo EJ
Korean J Lab Med; 2007 Dec; 27(6):388-93. PubMed ID: 18160827
[TBL] [Abstract][Full Text] [Related]
12. Core binding factor acute myeloid leukemia.
Paschka P
Semin Oncol; 2008 Aug; 35(4):410-7. PubMed ID: 18692691
[TBL] [Abstract][Full Text] [Related]
13. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
Byrd JC; Weiss RB; Arthur DC; Lawrence D; Baer MR; Davey F; Trikha ES; Carroll AJ; Tantravahi R; Qumsiyeh M; Patil SR; Moore JO; Mayer RJ; Schiffer CA; Bloomfield CD
J Clin Oncol; 1997 Feb; 15(2):466-75. PubMed ID: 9053467
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia (AML-M2) associated with variant t(8;21): report of three cases.
Bae SY; Kim JS; Ryeu BJ; Lee KN; Lee CK; Kim YK; Lim CS; Cho Y; Choi CW; Ryu SW; Yoon SY
Cancer Genet Cytogenet; 2010 May; 199(1):31-7. PubMed ID: 20417866
[TBL] [Abstract][Full Text] [Related]
15. Pediatric acute myeloid leukemia with t(7;21)(p22;q22).
Paulraj P; Diamond S; Razzaqi F; Ozeran JD; Longhurst M; Andersen EF; Toydemir RM; Hong B
Genes Chromosomes Cancer; 2019 Aug; 58(8):551-557. PubMed ID: 30706625
[TBL] [Abstract][Full Text] [Related]
16. Coexistent t(8;21)(q22;q22) Translocation and 5q Deletion in Acute Myeloid Leukemia.
Yamamoto K; Yakushijin K; Sanada Y; Kawamoto S; Matsuoka H; Minami H
J Clin Exp Hematop; 2015; 55(3):181-5. PubMed ID: 26763368
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of residual normal metaphases in acute myelogenous leukemia patients presenting with abnormal karyotype.
Ghaddar HM; Pierce S; Reed P; Estey EH
Leukemia; 1995 May; 9(5):779-82. PubMed ID: 7769840
[TBL] [Abstract][Full Text] [Related]
18. A rare cytogenetic presentation of acute myeloid leukemia (AML-M2).
Kumari P; LingappaKavitha B; Obula Reddy C; Mangalagowri M; Madhumathi DS; Mahadeva Prasad M; Raghavendra HV; Premalata CS; Lakshmaiah KC; Mir Mazloumi SH
Acta Med Iran; 2012; 50(12):827-30. PubMed ID: 23456526
[TBL] [Abstract][Full Text] [Related]
19. Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22).
Bacher U; Schnittger S; Kern W; Trenn G; Weisser M; Haferlach T; Schoch C
Cancer Genet Cytogenet; 2006 Jul; 168(2):172-4. PubMed ID: 16843110
[TBL] [Abstract][Full Text] [Related]
20. [Two cases of acute myeloid leukemia with t(16;21)(p11;q22) and TLS/FUS-ERG fusion transcripts].
Chang WR; Park IJ; Lee HW; Park JS; Kim HC; Kim HJ; Han JH; Cho SR
Korean J Lab Med; 2009 Oct; 29(5):390-5. PubMed ID: 19893346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
